bio-clinical-databases-hla-typing
Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for transplant matching, neoantigen prediction, or pharmacogenomic screening.
Best use case
bio-clinical-databases-hla-typing is best used when you need a repeatable AI agent workflow instead of a one-off prompt.
Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for transplant matching, neoantigen prediction, or pharmacogenomic screening.
Teams using bio-clinical-databases-hla-typing should expect a more consistent output, faster repeated execution, less prompt rewriting.
When to use this skill
- You want a reusable workflow that can be run more than once with consistent structure.
When not to use this skill
- You only need a quick one-off answer and do not need a reusable workflow.
- You cannot install or maintain the underlying files, dependencies, or repository context.
Installation
Claude Code / Cursor / Codex
Manual Installation
- Download SKILL.md from GitHub
- Place it in
.claude/skills/bio-clinical-databases-hla-typing/SKILL.mdinside your project - Restart your AI agent — it will auto-discover the skill
How bio-clinical-databases-hla-typing Compares
| Feature / Agent | bio-clinical-databases-hla-typing | Standard Approach |
|---|---|---|
| Platform Support | Not specified | Limited / Varies |
| Context Awareness | High | Baseline |
| Installation Complexity | Unknown | N/A |
Frequently Asked Questions
What does this skill do?
Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for transplant matching, neoantigen prediction, or pharmacogenomic screening.
Where can I find the source code?
You can find the source code on GitHub using the link provided at the top of the page.
SKILL.md Source
## Version Compatibility
Reference examples tested with: OptiType 1.3+, STAR 2.7.11+, pandas 2.2+, samtools 1.19+
Before using code patterns, verify installed versions match. If versions differ:
- Python: `pip show <package>` then `help(module.function)` to check signatures
- CLI: `<tool> --version` then `<tool> --help` to confirm flags
If code throws ImportError, AttributeError, or TypeError, introspect the installed
package and adapt the example to match the actual API rather than retrying.
# HLA Typing
**"Determine HLA genotype from my sequencing data"** → Call HLA alleles from WGS/WES/RNA-seq reads for transplant matching, neoantigen prediction, or pharmacogenomic screening.
- CLI: `OptiType` for HLA class I typing from DNA/RNA reads
- CLI: `arcasHLA extract` → `arcasHLA genotype` for RNA-seq based typing
## OptiType (HLA Class I)
**Goal:** Call HLA Class I alleles (HLA-A, B, C) at 4-field resolution from WGS, WES, or RNA-seq data.
**Approach:** Extract HLA region reads from BAM, then run OptiType's integer linear programming algorithm to determine optimal allele assignment.
### From DNA-seq
```bash
# Extract HLA reads from BAM
samtools view -h input.bam chr6:28000000-34000000 | \
samtools fastq -1 hla_R1.fq -2 hla_R2.fq -
# Run OptiType
OptiTypePipeline.py \
-i hla_R1.fq hla_R2.fq \
-d \
-o optitype_output \
-c config.ini
# Output: optitype_output/sample_result.tsv
# Contains HLA-A, HLA-B, HLA-C alleles (4-field resolution)
```
### From RNA-seq
```bash
# RNA mode
OptiTypePipeline.py \
-i rna_R1.fq rna_R2.fq \
-r \
-o optitype_rna_output \
-c config.ini
```
### OptiType Config
```ini
# config.ini
[mapping]
razers3=/path/to/razers3
threads=4
[ilp]
solver=glpk
threads=4
[behavior]
deletebam=true
unpaired_weight=0
use_discordant=false
```
## HLA-HD (Full Resolution)
**Goal:** Perform high-resolution HLA typing for both Class I and Class II loci from WGS/WES data.
**Approach:** Extract HLA-region reads, then run HLA-HD which uses Bowtie2 mapping against the IPD-IMGT/HLA database.
```bash
# HLA-HD for high-resolution typing
# Supports Class I and Class II
# Extract HLA reads
samtools view -b input.bam chr6:28000000-34000000 > hla_region.bam
samtools sort -n hla_region.bam -o hla_sorted.bam
samtools fastq -1 hla_R1.fq -2 hla_R2.fq hla_sorted.bam
# Run HLA-HD
hlahd.sh \
-t 8 \
-m 100 \
-f freq_data \
hla_R1.fq \
hla_R2.fq \
gene_split_filt \
dictionary \
sample_name \
output_dir
# Output includes HLA-A, B, C, DRB1, DQB1, DPB1 at 4-field resolution
```
## arcasHLA (RNA-seq)
**Goal:** Genotype HLA alleles directly from RNA-seq BAM files aligned with STAR.
**Approach:** Extract HLA-mapped reads with arcasHLA extract, then genotype using an EM algorithm against the IMGT/HLA database.
```bash
# Fast HLA typing from RNA-seq
# Extracts and genotypes in one step
# From STAR-aligned BAM
arcasHLA extract sample.bam -o output_dir
arcasHLA genotype output_dir/sample.extracted.fq.gz -o output_dir
# Output: sample.genotype.json
# {
# "A": ["A*02:01", "A*24:02"],
# "B": ["B*35:01", "B*44:03"],
# "C": ["C*04:01", "C*05:01"]
# }
```
### arcasHLA Merge
```bash
# Merge multiple samples
arcasHLA merge output_dir/*.genotype.json -o merged_hla.tsv
```
## HLA Nomenclature
```
HLA-A*02:01:01:01
| | | |
| | | +-- Non-coding variation (optional)
| | +----- Synonymous variation (optional)
| +-------- Protein sequence (usually reported)
+----------- Allele group
Resolution levels:
- 2-field: A*02:01 (protein sequence - clinical standard)
- 4-field: A*02:01:01 (includes synonymous changes)
- Full: A*02:01:01:01 (includes non-coding)
```
## HLA and Pharmacogenomics
**Goal:** Screen patient HLA alleles for known drug hypersensitivity associations.
**Approach:** Cross-reference called HLA alleles against a curated table of HLA-drug adverse reaction associations.
```python
# Key HLA-drug associations
HLA_DRUG_ASSOCIATIONS = {
'B*57:01': {
'drug': 'Abacavir',
'reaction': 'Hypersensitivity syndrome',
'screening': 'Required before prescribing'
},
'B*15:02': {
'drug': 'Carbamazepine',
'reaction': 'SJS/TEN',
'populations': 'High risk in Han Chinese, Southeast Asian'
},
'B*58:01': {
'drug': 'Allopurinol',
'reaction': 'SJS/TEN',
'populations': 'High risk in Han Chinese, Korean, Thai'
},
'A*31:01': {
'drug': 'Carbamazepine',
'reaction': 'DRESS',
'populations': 'European, Japanese'
}
}
def check_hla_drug_risk(hla_alleles, drug):
'''Check if patient HLA poses drug reaction risk'''
risks = []
for allele in hla_alleles:
if allele in HLA_DRUG_ASSOCIATIONS:
assoc = HLA_DRUG_ASSOCIATIONS[allele]
if assoc['drug'].lower() == drug.lower():
risks.append({
'allele': allele,
'drug': drug,
'reaction': assoc['reaction']
})
return risks
```
## Parse OptiType Results
**Goal:** Parse OptiType TSV output into structured HLA calls and format for clinical reporting.
**Approach:** Read the tab-separated result file and extract allele pairs for each HLA locus.
```python
import pandas as pd
def parse_optitype(result_file):
'''Parse OptiType TSV output'''
df = pd.read_csv(result_file, sep='\t')
# Columns: A1, A2, B1, B2, C1, C2, Reads, Objective
hla_calls = {
'HLA-A': [df['A1'].iloc[0], df['A2'].iloc[0]],
'HLA-B': [df['B1'].iloc[0], df['B2'].iloc[0]],
'HLA-C': [df['C1'].iloc[0], df['C2'].iloc[0]]
}
return hla_calls
def format_hla_report(hla_calls):
'''Format HLA calls for clinical report'''
report = []
for gene, alleles in hla_calls.items():
allele_str = '/'.join(sorted(set(alleles)))
report.append(f'{gene}: {allele_str}')
return '\n'.join(report)
```
## Class I vs Class II
| Class | Genes | Function | Typing Priority |
|-------|-------|----------|-----------------|
| Class I | HLA-A, B, C | Present intracellular peptides | Neoantigen, PGx |
| Class II | HLA-DR, DQ, DP | Present extracellular peptides | Transplant, autoimmune |
## Tool Comparison
| Tool | Input | Classes | Resolution | Speed |
|------|-------|---------|------------|-------|
| OptiType | WGS/WES/RNA | I only | 4-field | Fast |
| HLA-HD | WGS/WES | I and II | 4-field | Moderate |
| arcasHLA | RNA-seq | I and II | 4-field | Fast |
| HLA-LA | WGS | I and II | 4-field | Slow |
## Related Skills
- clinical-databases/pharmacogenomics - HLA-drug interactions
- variant-calling/clinical-interpretation - Clinical reporting
- single-cell/cell-type-annotation - HLA expressionRelated Skills
tooluniverse-clinical-trial-matching
AI-driven patient-to-trial matching for precision medicine and oncology. Given a patient profile (disease, molecular alterations, stage, prior treatments), discovers and ranks clinical trials from ClinicalTrials.gov using multi-dimensional matching across molecular eligibility, clinical criteria, drug-biomarker alignment, evidence strength, and geographic feasibility. Produces a quantitative Trial Match Score (0-100) per trial with tiered recommendations and a comprehensive markdown report. Use when oncologists, molecular tumor boards, or patients ask about clinical trial options for specific cancer types, biomarker profiles, or post-progression scenarios.
tooluniverse-clinical-trial-design
Strategic clinical trial design feasibility assessment using ToolUniverse. Evaluates patient population sizing, biomarker prevalence, endpoint selection, comparator analysis, safety monitoring, and regulatory pathways. Creates comprehensive feasibility reports with evidence grading, enrollment projections, and trial design recommendations. Use when planning Phase 1/2 trials, assessing trial feasibility, or designing biomarker-driven studies.
tooluniverse-clinical-guidelines
Search and retrieve clinical practice guidelines across 12+ authoritative sources including NICE, WHO, ADA, AHA/ACC, NCCN, SIGN, CPIC, CMA, CTFPHC, GIN, MAGICapp, PubMed, EuropePMC, TRIP, and OpenAlex. Covers disease management, cardiology, oncology, diabetes, pharmacogenomics, and more. Use when users ask about clinical guidelines, treatment recommendations, standard of care, evidence-based medicine, or drug-gene dosing recommendations.
clinicaltrials-database
Query ClinicalTrials.gov via API v2. Search trials by condition, drug, location, status, or phase. Retrieve trial details by NCT ID, export data, for clinical research and patient matching.
clinical-trials-search
Search ClinicalTrials.gov with natural language queries. Find clinical trials, enrollment, and outcomes using Valyu semantic search.
clinical-trial-protocol-skill
Generate clinical trial protocols for medical devices or drugs. This skill should be used when users say "Create a clinical trial protocol", "Generate protocol for [device/drug]", "Help me design a clinical study", "Research similar trials for [intervention]", or when developing FDA submission documentation for investigational products.
clinical-reports
Write comprehensive clinical reports including case reports (CARE guidelines), diagnostic reports (radiology/pathology/lab), clinical trial reports (ICH-E3, SAE, CSR), and patient documentation (SOAP, H&P, discharge summaries). Full support with templates, regulatory compliance (HIPAA, FDA, ICH-GCP), and validation tools.
clinical-diagnostic-reasoning
Identify and counteract cognitive biases in medical decision-making through systematic error analysis and contextual algorithm application. For diagnostic reasoning, treatment decisions, and clinical judgment improvement. NOT for basic medical knowledge, technical procedures, or non-clinical healthcare domains.
clinical-decision-support
Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). Supports GRADE evidence grading, statistical analysis (hazard ratios, survival curves, waterfall plots), biomarker integration, and regulatory compliance. Outputs publication-ready LaTeX/PDF format optimized for drug development, clinical research, and evidence synthesis.
bio-variant-calling-clinical-interpretation
Clinical variant interpretation using ClinVar, ACMG guidelines, and pathogenicity predictors. Prioritize variants for diagnostic and research applications. Use when interpreting clinical significance of variants.
bio-imaging-mass-cytometry-phenotyping
Cell type assignment from marker expression in IMC data. Covers manual gating, clustering, and automated classification approaches. Use when assigning cell types to segmented IMC cells based on protein marker expression or when phenotyping cells in multiplexed imaging data.
bio-flow-cytometry-clustering-phenotyping
Unsupervised clustering and cell type identification for flow/mass cytometry. Covers FlowSOM, Phenograph, and CATALYST workflows. Use when discovering cell populations in high-dimensional cytometry data without predefined gates.